Skip to main content

Table 1 Demographic characteristics of study participants

From: Inhaled corticosteroid influence toll like receptor 2 expression in induced sputum from patients with COPD

  ICS group (n = 21) ICS naïve group (n = 29) P value
Age (years) 66 (79–54) 68 (84–56) 0.86
Gender (female/male) 0/21 0/29 1
Duration of COPD (year) 5 (1–25) 4 (0.5–21) 0.15
Smokers/ex-smokers 9/21 14/29 -
Smoking (pack/year) 56 (82–20) 55 (60–20) 0.76
BMI (kg/m2) 27 (35–20) 26 (38–19) 0.23
Post BD FEV1 (%predicted) 43% (15–50) 48% (17–49) 0.47
FEV1/FVC 32% (12-46%) 36% (20-54%) 0.13
MRC† Dyspnoea Score 2 (2–3) 2 (2–3) 0.61
Hospitalization in the previous year (number) 0.5 (0–1) 0.4 (0–1) 0.14
Pneumonia in the previous 3 years (number) 0.6 (0–1) 0.5 (0–1) 0.07
Non of ER visit because of exacerbation of COPD in the previous year (number) 1.1 (1–3) 1.0 (1–2) 0.09
  1. †: MRC = Modified Medical Council.
  2. Data represents: mean (range).